form8-k.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
_____________________________
 
FORM 8-K
 

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
_____________________________
 
Date of Report (Date of earliest event reported):  February 11, 2009
 
Orthofix International N.V.
(Exact name of Registrant as specified in its charter)
 
Netherlands Antilles
  
0-19961
  
N/A
(State or other jurisdiction of incorporation)
  
Commission File Number
  
(I.R.S. Employer Identification Number)
_____________________________
 
7 Abraham de Veerstraat
Curaçao
 
Netherlands Antilles
N/A
 
(Address of principal executive offices)
(Zip Code)

Registrant’s telephone number, including area code:  011-59-99-465-8525
_____________________________
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.):
 
£
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
T
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
£
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
£
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 

Item 7.01.   Regulation FD Disclosure
 
On February 11, 2009, Orthofix International N.V. (the “Company”) issued a press release (the “press release”) announcing that the expected release date for Trinity®  Evolution™ has been accelerated. A copy of the press release is furnished herewith and attached hereto.
 
This information shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth in the specific reference in such a filing.


Item 9.01.   Financial Statements and Exhibits
 
(c)  Exhibits

99.1 Press release of Orthofix International N.V. dated February 11, 2009.

 
 
 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 
   
ORTHOFIX INTERNATIONAL N.V.
       
       
Dated:  February 11, 2009
  
By:
/s/ Robert S. Vaters
     
Name:
Robert S. Vaters
     
Title:
Executive Vice President and Chief Financial Officer

 
 
 

EXHIBIT INDEX
 
Exhibit No.
  
Description
               
 
Press release of Orthofix International N.V. dated February 11, 2009.